These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33323410)

  • 21. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid.
    Raka F; Di Sebastiano AR; Kulhawy SC; Ribeiro FM; Godin CM; Caetano FA; Angers S; Ferguson SS
    Mol Brain; 2015 Mar; 8():21. PubMed ID: 25885040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
    Folch J; Petrov D; Ettcheto M; Abad S; Sánchez-López E; García ML; Olloquequi J; Beas-Zarate C; Auladell C; Camins A
    Neural Plast; 2016; 2016():8501693. PubMed ID: 26881137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
    Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
    Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.
    Cimino PJ; Yang Y; Li X; Hemingway JF; Cherne MK; Khademi SB; Fukui Y; Montine KS; Montine TJ; Keene CD
    Exp Mol Pathol; 2013 Apr; 94(2):366-71. PubMed ID: 23318649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [
    Fang XT; Eriksson J; Antoni G; Yngve U; Cato L; Lannfelt L; Sehlin D; Syvänen S
    Neuropharmacology; 2017 Feb; 113(Pt A):293-300. PubMed ID: 27743932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
    Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
    Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease.
    Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS
    J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity.
    Limegrover CS; LeVine H; Izzo NJ; Yurko R; Mozzoni K; Rehak C; Sadlek K; Safferstein H; Catalano SM
    J Neurochem; 2021 May; 157(4):1316-1330. PubMed ID: 33025581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
    Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
    J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
    Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
    Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.
    Liu P; Paulson JB; Forster CL; Shapiro SL; Ashe KH; Zahs KR
    PLoS One; 2015; 10(5):e0126317. PubMed ID: 25946042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment.
    Yi JH; Kwon H; Cho E; Jeon J; Lee J; Lee YC; Cho JH; Jun M; Moon M; Ryu JH; Kim JS; Choi JW; Park SJ; Lee S; Kim DH
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.